Delivery Order SPE2DB25D3020-SPE2DB25FWJCS
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a prescription medication, with a ceiling value of $11,830.00 and a completion date of July 3, 2025. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, with a ceiling value of $12,604.63 and a performance period extending through June 12, 2025. The contract is not set aside and was awarded on May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The contract has a period of performance through April 22, 2025 and is a firm fixed price contract. No set-aside requirements were noted. AmerisourceBergen also holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract has a ceiling value of $11,830.00 and is a firm fixed price delivery order with a period of performance through July 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,827.51, is for the delivery of the pharmaceutical product SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The contract is a firm fixed-price delivery order with a completion date of December 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $12,604.63 and a performance period through May 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML, a specialty medication, with a ceiling value of $25,209.26 and a period of performance through March 2025. The contract is a firm fixed-price, delivery order contract and was not set aside for any specific business type....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product, with a ceiling value of $11,830.00 and a period of performance through July 23, 2025. The contract is not designated as a set-aside and was awarded on a firm-fixed-price basis. AmerisourceBergen Drug Corp, the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract has a ceiling value of $11,830.00 and a completion date of July 31, 2025. It is a firm fixed-price contract, indicating the price is set and will not change. This contract is not a set-aside, meaning it was openly...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $11,827.51, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price arrangement with a period of performance through November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJCSDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a medication, with a ceiling value of $11,830.00 and a performance period ending on July 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 6/23/25 |